Metraipolis › archive › dc_ff249c56ac28
Novel Combination of Mesenchymal Stem Cell-Conditioned Medium with Sorafenib Have Synergistic Antitumor Effect of Hepatocellular Carcinoma Cells — Europe PMC PMID:30678447
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/30678447
- DOI
- 10.31557/apjcp.2019.20.1.263
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-03T21:25:52.133Z
- SHA-256 of the archived text
23627f573d1e6c09a36485bfe1ba7aff6682ca48134d9641d46512d1dda7fa99- Stable URL of this page
https://metraipolis.com/documento/dc_ff249c56ac28
How to cite
Novel Combination of Mesenchymal Stem Cell-Conditioned Medium with Sorafenib Have Synergistic Antitumor Effect of Hepatocellular Carcinoma Cells — Europe PMC PMID:30678447 — Europe PMC (en), https://europepmc.org/article/MED/30678447 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ff249c56ac28 (Metraipolis archive dc_ff249c56ac28, sha256 23627f573d1e6c09a36485bfe1ba7aff6682ca48134d9641d46512d1dda7fa99)
BibTeX
@misc{dcff249c56ac28,
title = {Novel Combination of Mesenchymal Stem Cell-Conditioned Medium with Sorafenib Have Synergistic Antitumor Effect of Hepatocellular Carcinoma Cells — Europe PMC PMID:30678447},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/30678447},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ff249c56ac28; sha256 23627f573d1e6c09a36485bfe1ba7aff6682ca48134d9641d46512d1dda7fa99},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/30678447. Agents can read the archived copy with the MCP tool read_document.